Abstract
Black and Latino adult cancer patients are underrepresented in cancer clinical trials, which limits generalizability of findings and amplifies disparities in healthcare access and outcomes. Community-level education programs designed to address barriers to participation could improve representation in cancer clinical trials. Through a community–campus partner framework, this study evaluated the Women United: Clinical Trials and the Fight Against Breast Cancer Program in Spanish and English. Participants were 422 women (141 Black, 140 Latina Spanish preference, 141 Latina English preference) who were randomized to view either the intervention (n = 215) or a control (n = 207) program. Assessments of clinical trials knowledge and barriers to clinical trials participation were taken before and after viewing. Results suggested that clinical trials knowledge increased and perceived barriers to participation decreased for those who viewed the educational program. More specifically, those in the intervention condition perceived fewer barriers related to personal benefits, mistrust, and familiarity of clinical trials. As expected, there were no differences in perceived barriers related to community support for either condition. Participants in both conditions were equally likely to join a subsequent study or a clinical trials community ambassador program. There were no differences in any of the outcomes across ethnicity or language, suggesting the program works equivalently across groups. This program is easy to administer and can be recommended for use among Black and Latina women to address factors related to clinical trials participation.
Similar content being viewed by others
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Code Availability
The SPSS code that support the findings of this study are available from the corresponding author upon reasonable request.
Change history
25 April 2022
A Correction to this paper has been published: https://doi.org/10.1007/s13187-022-02174-8
Notes
A descriptive table containing the pre- and post-test results for clinical trials knowledge, barriers, and behavioral outcomes for the intervention and control conditions by ethnicity/language is available from the authors on request.
References
Unger JM, Vaidya R, Hershman DL et al (2019) Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. J Natl Cancer Inst 111:245–255
Loree JM, Anand S, Dasari A et al (2019) Disparity of race reporting and representation in clinical trials leading to cancer drug approvals from 2008 to 2018. JAMA Oncol 5:e191870
Unger JM, Gralow JR, Albain KS et al (2016) Patient income level and cancer clinical trial participation: A prospective survey study. JAMA Oncol 2:137–139
Unger JM, Hershman DL, Till C et al (2021) “When Offered to Participate”: A systematic review and meta-analysis of patient agreement to participate in cancer clinical trials. J Natl Cancer Inst 113:244–257
Schmotzer GL (2012) Barriers and facilitators to participation of minorities in clinical trials. Ethn Dis 22:226–230
Trant AA, Walz L, Allen W et al (2020) Increasing accrual of minority patients in breast cancer clinical trials. Breast Cancer Res Treat 184:499–505
Garza MA, Quinn SC, Li Y et al (2017) The influence of race and ethnicity on becoming a human subject: Factors associated with participation in research. Contemp Clin Trials Commun 7:57–63
Symonds RP, Lord K, Mitchell AJ, Raghavan D (2012) Recruitment of ethnic minorities into cancer clinical trials: Experience from the front lines. Br J Cancer 107:1017–1021
Penberthy L, Brown R, Wilson-Genderson M et al (2012) Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment. Clin Trials 9:788–797
Powell JH, Fleming Y, Walker-McGill CL, Lenoir M (2008) The project IMPACT experience to date: increasing minority participation and awareness of clinical trials. J Natl Med Assoc 100:178–187
Rosenstock IM, Strecher VJ, Becker MH (1988) Social learning theory and the Health Belief Model. Heal Educ !uarterly 15:175–183
Heller C, Balls-Berry JE, Nery JD et al (2014) Strategies addressing barriers to clinical trial enrollment of underrepresented populations: a systematic review. Contemp Clin Trials 39:169–182
Cunningham-Erves J, Mayo-Gamble TL, Hull PC et al (2021) A pilot study of a culturally-appropriate, educational intervention to increase participation in cancer clinical trials among African Americans and Latinos. Cancer Causes Control 32:953–963
Pelto DJ, Sadler GR, Njoku O et al (2017) Adaptation of a cancer clinical trials education program for African American and Latina/o community members. Health Educ Behav 43:381–388. https://doi.org/10.1177/1090198115610555
Ma GX, Tan Y, Blakeney NC et al (2014) The impact of a community-based clinical trial educational intervention among underrepresented Chinese Americans. Cancer Epidemiol Biomarkers Prev 23:424–432
Skinner JS, Fair AM, Holman AS et al (2019) The impact of an educational video on clinical trial enrollment and knowledge in ethnic minorities: A randomized control trial. Front Public Heal 7:1–7
Sadler GR, Gonzalez J, Mumman M et al (2010) Adapting a program to inform African American and Hispanic American women about cancer clinical trials. J Cancer Educ 25:142–145
Michaels M, Weiss ES, Guidry JA et al (2012) The promise of community-based advocacy and education efforts for increasing cancer clinical trials accrual. J Cancer Educ 27:67–74
Malcarne VL, Aldridge A, Roesch SC et al (2008) Translating and validating instruments for diverse communities: The Barriers to Clinical Trials Participation Scale. J Cancer Educ 23:19
Malcarne VL, Aldridge-Gerry A, Roesch SC, et al Development and psychometric evaluation of the Barriers to Clinical Trials Participation Scale. Manuscript in preparation
Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24:385–396
Acknowledgements
The authors wish to thank all the participants who gave their time to
voluntarily join this study. The authors also thank the following organizations for their assistance with recruitment: North County Latina Association, North County African American Women's Association, Friendly Church of God in Christ. The authors also wish to acknowledge Courtney Carter, Viridiana Conde, Erika Sosa, and Daphne Summers-Torres from the Vista Community Clinic, and undergraduate students who assisted with this study: Cecilia Bess, Kadie Harry, Anna-Michelle McSorley, Abraham Nguyen, Lisa Nguyen, Anthony Orona, Jessica Petzold, Vincenzo Roma, and DeAna Thomas.
Funding
redacted for blind review.
Author information
Authors and Affiliations
Contributions
redacted for blind review.
Corresponding author
Ethics declarations
Ethics Approval
Ethics approval was obtained through the local institutional review boards at [redacted for blind review].
Consent to Participate
All participants provided written informed consent.
Consent for Publication
Not applicable. Data are de-identified and presented in pooled form.
Conflicts of Interest/Competing Interest
None declared.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original version of this article was revised. The co-author Vanessa Malcarne’s ORCID number is 0000-0002-7526-9982.
Rights and permissions
About this article
Cite this article
Merz, E.L., Riley, N.E., Malcarne, V.L. et al. Clinical trials-related knowledge, attitudes, and behaviors among Black and Latina women: A randomized controlled trial of the Women United: Clinical Trials and the Fight Against Breast Cancer Program. J Canc Educ 37, 874–881 (2022). https://doi.org/10.1007/s13187-022-02162-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-022-02162-y